Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2009 1
2010 1
2011 4
2012 2
2013 2
2014 3
2015 5
2016 2
2017 2
2018 1
2019 2
2021 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Resolving the fibrotic niche of human liver cirrhosis at single-cell level.
Ramachandran P, Dobie R, Wilson-Kanamori JR, Dora EF, Henderson BEP, Luu NT, Portman JR, Matchett KP, Brice M, Marwick JA, Taylor RS, Efremova M, Vento-Tormo R, Carragher NO, Kendall TJ, Fallowfield JA, Harrison EM, Mole DJ, Wigmore SJ, Newsome PN, Weston CJ, Iredale JP, Tacke F, Pollard JW, Ponting CP, Marioni JC, Teichmann SA, Henderson NC. Ramachandran P, et al. Nature. 2019 Nov;575(7783):512-518. doi: 10.1038/s41586-019-1631-3. Epub 2019 Oct 9. Nature. 2019. PMID: 31597160 Free PMC article.
Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis.
Ramachandran P, Pellicoro A, Vernon MA, Boulter L, Aucott RL, Ali A, Hartland SN, Snowdon VK, Cappon A, Gordon-Walker TT, Williams MJ, Dunbar DR, Manning JR, van Rooijen N, Fallowfield JA, Forbes SJ, Iredale JP. Ramachandran P, et al. Proc Natl Acad Sci U S A. 2012 Nov 13;109(46):E3186-95. doi: 10.1073/pnas.1119964109. Epub 2012 Oct 24. Proc Natl Acad Sci U S A. 2012. PMID: 23100531 Free PMC article.
Emerging synthetic drugs for the treatment of liver cirrhosis.
Fallowfield JA, Jimenez-Ramos M, Robertson A. Fallowfield JA, et al. Expert Opin Emerg Drugs. 2021 Jun;26(2):149-163. doi: 10.1080/14728214.2021.1918099. Epub 2021 Apr 26. Expert Opin Emerg Drugs. 2021. PMID: 33856246 Review.
Therapeutic targets in liver fibrosis.
Fallowfield JA. Fallowfield JA. Am J Physiol Gastrointest Liver Physiol. 2011 May;300(5):G709-15. doi: 10.1152/ajpgi.00451.2010. Epub 2011 Jan 13. Am J Physiol Gastrointest Liver Physiol. 2011. PMID: 21233278 Free article. Review.
Models and mechanisms of fibrosis resolution.
Snowdon VK, Fallowfield JA. Snowdon VK, et al. Alcohol Clin Exp Res. 2011 May;35(5):794-9. doi: 10.1111/j.1530-0277.2010.01400.x. Epub 2011 Feb 1. Alcohol Clin Exp Res. 2011. PMID: 21284668 Review.
A relaxin-based nanotherapy for liver fibrosis.
Fallowfield JA, Ramachandran P. Fallowfield JA, et al. Nat Nanotechnol. 2021 Apr;16(4):365-366. doi: 10.1038/s41565-020-00832-w. Nat Nanotechnol. 2021. PMID: 33495619 No abstract available.
27 results